General
York County Now A Part Of The Fight Against Opioid
York County joined statewide and national fight against opioid companies for the devastating opioid crisis. A 283-page complaint blaming Purdue Pharma, Johnson…
EU Court Asks EFSA To Reveal Glyphosate Cancer Studies
On Thursday, EU court ruled that the European Food Safety Agency (EFSA) must disclose to European lawmakers the details of studies about the dangers and carcinogenic nature of glyphosate in support of the campaigners who want…
Will Roundup Trial End in Mistrial? Know the Case Progress
On March 6, a pathologist testified during a federal bellwether trial that Roundup weedkiller was a substantial cause of cancer in humans and refuted…
Purdue Pharma’s Bankruptcy Filing Might Delay Opioid Trial
On March 4, Monday, Reuters reported that Purdue Pharma was considering to file for Chapter 11 bankruptcy, as it faces over 2,000 lawsuits over allegations that it contributed to America’s deadly…
Incorrect Packaging Leads To Recall of Birth Control Pill
On March 4, the FDA advised a nationwide birth control pill recall by Apotex Corp. impacting four lots of Drospirenone and Ethinyl Estradiol tablets, which may have placebo pills in the wrong area or missing tablets.
The…
Miami City Bans Glyphosate-based Herbicides
Miami became the latest to ban herbicides containing glyphosate as an active ingredient in them. Glyphosate is found in weed-killing herbicides like Roundup…
Arthrex Knee Implant Suit Moves Forward in Pa. Federal Court
In an order issued on February 27, Judge A. Richard Caputo of the U.S. District Court for the Middle District of Pennsylvania refused to toss a lawsuit involving complaints against Arthrex Inc.'s iBalance knee implant, ruling that the…
Mass. High Court Affirms 6-year Limit For Asbestos Claims
On Friday, March 1, the Massachusetts Supreme Judicial Court ruled that the six-year statute of limitations for construction tort claims was applicable to diseases with long latency periods, such as those linked to…
Nearly 90 Lots Of Losartan Recalled Over Carcinogen Presence
The U.S. Food & Drug Administration (FDA) found a third type of carcinogen called N-Nitroso N-Methyl 4-aminobutyric acid (NMBA) in the popular blood pressure medicine Losartan and announced a recall on February 28, 2019.
…Direct Filing Into The MDL Granted For Atrium C-Qur Cases
U.S. District Judge Landya McCafferty presiding over all Atrium hernia mesh lawsuits approved new procedures in a case management order issued on February 19,…